U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. Transparency
  4. FDA-TRACK: Agency-wide Program Performance
  5. FDA-TRACK: What's New
  1. FDA-TRACK: Agency-wide Program Performance

 

FDA-TRACK is committed to providing you with the latest available performance data from across the Agency. Check the What's New page often to see the latest updates. Sign-up to receive the FDA-TRACK Newsletter and have updates delivered right to your inbox.

 

Drug

FDA-TRACK FY22 Data Updates

FDA-TRACK has released FY22 performance data. Review the FDA-TRACK product dashboards to see what FDA has accomplished towards its strategic goals in FY22.


User Fee Programs

User Fee Programs

Preliminary FY 2022 performance goal data is available for the FDA ADUFA and AGDUFA User Fee Programs. Check back in the coming months for updates to PDUFA and BsUFA.


Drug

New NCTR Key Projects

The National Center for Toxicological Research has developed two new Key Projects: 'Assessing the Effects of Methadone or Buprenorphine and their Combined Use with Cannabinoids on Human Neural Stem Cells' and 'Investigating Early Signs of Sex-Difference in Adverse Drugs Effects to Better Protect Women’s Health'.

 

Subscribe

Sign up to receive FDA-TRACK updates

Back to Top